Market Cap ₹14 Cr.
Stock P/E 2.9
P/B -
Current Price ₹48
Book Value ₹ 0
Face Value 10
52W High ₹0
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 19 | 33 | 27 | 48 | 48 | 58 | 59 | 66 | 52 | 62 |
Other Income | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Total Income | 20 | 33 | 27 | 49 | 50 | 60 | 59 | 67 | 53 | 63 |
Total Expenditure | 20 | 29 | 29 | 50 | 49 | 55 | 55 | 65 | 53 | 60 |
Operating Profit | 0 | 4 | -2 | -0 | 0 | 4 | 4 | 2 | -0 | 3 |
Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -1 | 2 | -3 | -2 | -1 | 3 | 3 | 1 | -1 | 2 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
Profit After Tax | -1 | 2 | -3 | -2 | -1 | 3 | 3 | 1 | -1 | 2 |
Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | -1 | 2 | -3 | -2 | -1 | 3 | 3 | 1 | -1 | 2 |
Adjusted Earnings Per Share | -3.8 | 7.3 | -10.2 | -6 | -4.1 | 10 | 11.2 | 3.1 | -4.9 | 7.4 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 35 | 37 | 40 | 43 | 290 | 307 | 248 | 37 | 87 | 214 | 239 |
Other Income | 2 | 2 | 2 | 3 | 6 | 7 | 5 | 2 | 3 | 4 | 3 |
Total Income | 36 | 39 | 41 | 47 | 297 | 314 | 253 | 40 | 90 | 218 | 242 |
Total Expenditure | 32 | 34 | 36 | 41 | 291 | 306 | 249 | 41 | 88 | 210 | 233 |
Operating Profit | 4 | 5 | 5 | 5 | 6 | 8 | 4 | -1 | 2 | 8 | 9 |
Interest | 2 | 3 | 3 | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 |
Depreciation | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | -0 | 0 | 1 | 0 | 1 | -2 | -6 | -3 | 3 | 5 |
Provision for Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -0 | 0 |
Profit After Tax | 0 | -0 | 0 | 0 | 0 | 1 | -2 | -7 | -3 | 3 | 5 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | -0 | 0 | 0 | 0 | 1 | -2 | -7 | -3 | 3 | 5 |
Adjusted Earnings Per Share | 1.1 | -0.6 | 1.3 | 1.5 | 1.3 | 4.2 | -5.6 | -24.1 | -10.5 | 11.1 | 16.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 146% | -5% | -6% | 0% |
Operating Profit CAGR | 300% | 26% | 6% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 0% | -3% | -7% | -4% |
ROE Average | 0% | 0% | 0% | 0% |
ROCE Average | 164% | 55% | 45% | 43% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | -8 | -9 | -8 | -8 | -8 | -7 | -9 | -16 | -19 | -17 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 4 | 6 | 7 | 6 | 6 | 9 | 9 | 11 | 19 | 20 |
Other Non-Current Liabilities | 5 | 6 | 8 | 9 | 13 | 16 | 19 | 18 | 14 | 12 |
Total Current Liabilities | 49 | 46 | 49 | 53 | 56 | 48 | 46 | 48 | 42 | 41 |
Total Liabilities | 49 | 49 | 55 | 60 | 68 | 66 | 64 | 60 | 56 | 55 |
Fixed Assets | 19 | 21 | 20 | 21 | 24 | 25 | 27 | 26 | 24 | 23 |
Other Non-Current Assets | 1 | 1 | 1 | 1 | 4 | 4 | 5 | 2 | 1 | 1 |
Total Current Assets | 29 | 27 | 34 | 39 | 39 | 37 | 32 | 33 | 30 | 31 |
Total Assets | 49 | 49 | 55 | 60 | 68 | 66 | 64 | 60 | 56 | 55 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 3 | 3 | 3 | 2 | 4 | 3 | 2 | 3 | 4 | 3 |
Cash Flow from Operating Activities | 5 | 6 | 3 | 7 | 3 | 4 | 5 | 3 | 3 | 5 |
Cash Flow from Investing Activities | -3 | -4 | -1 | -2 | -4 | -2 | -2 | 1 | 0 | -0 |
Cash Flow from Financing Activities | -2 | -2 | -3 | -3 | 0 | -3 | -3 | -3 | -4 | -4 |
Net Cash Inflow / Outflow | -0 | -0 | -0 | 1 | -1 | -1 | 0 | 1 | -0 | 1 |
Closing Cash & Cash Equivalent | 3 | 3 | 2 | 4 | 3 | 2 | 3 | 4 | 3 | 5 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.1 | -0.65 | 1.33 | 1.46 | 1.29 | 4.15 | -5.65 | -24.11 | -10.5 | 11.11 |
CEPS(Rs) | 5.42 | 7.21 | 6.25 | 6.16 | 6.07 | 9.53 | -0.55 | -19.32 | -5.88 | 15.73 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | -30.11 | -30.75 | -29.42 | -27.96 | -26.78 | -25.66 | -32.39 | -56.44 | -66.37 | -58.66 |
Core EBITDA Margin(%) | 7.32 | 7.79 | 8.79 | 4.77 | -0.27 | 0.1 | -0.63 | -8.39 | -0.61 | 1.92 |
EBIT Margin(%) | 8.82 | 7.11 | 8.88 | 9.04 | 1.47 | 1.95 | 0.92 | -6.59 | 1 | 3.26 |
Pre Tax Margin(%) | 1.9 | -0.63 | 1.11 | 1.33 | 0.17 | 0.48 | -0.64 | -17.11 | -3.35 | 1.38 |
PAT Margin (%) | 0.96 | -0.53 | 1 | 1.01 | 0.13 | 0.41 | -0.68 | -19.29 | -3.62 | 1.56 |
Cash Profit Margin (%) | 4.7 | 5.92 | 4.7 | 4.27 | 0.63 | 0.93 | -0.07 | -15.46 | -2.03 | 2.21 |
ROA(%) | 0.67 | -0.4 | 0.77 | 0.76 | 0.6 | 1.86 | -2.6 | -11.62 | -5.42 | 6.01 |
ROE(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ROCE(%) | 38.64 | 39.04 | 49.47 | 40.52 | 37.51 | 46.94 | 12.47 | -15.41 | 15.46 | 164.48 |
Receivable days | 201.36 | 180.32 | 171.78 | 188.76 | 30.44 | 28.7 | 33.16 | 172.31 | 72.02 | 34.7 |
Inventory Days | 15.97 | 15.37 | 16.81 | 20.13 | 4.34 | 4.39 | 4.16 | 21.09 | 7.13 | 2.58 |
Payable days | 2297.85 | 2118.25 | 2243.88 | 2110.65 | 65.17 | 74.97 | 74.57 | 785.1 | 389.61 | 114.29 |
PER(x) | 68.1 | 0 | 86.32 | 54.08 | 49.51 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | -2.49 | -3.69 | -3.91 | -2.83 | -2.38 | 0 | 0 | -0.89 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.06 | 1.26 | 1.25 | 0.89 | 0.12 | 0.07 | 0.14 | 0.98 | 0.25 | 0.1 |
EV/Core EBITDA(x) | 8.75 | 9.3 | 9.92 | 7.27 | 6.35 | 2.82 | 8.81 | -35.62 | 9.84 | 2.6 |
Net Sales Growth(%) | 0 | 5.69 | 9.08 | 8.6 | 570.14 | 5.72 | -19.19 | -84.88 | 132.17 | 145.41 |
EBIT Growth(%) | 0 | -14.82 | 36.35 | 10.49 | 8.96 | 40.54 | -61.8 | -207.87 | 135.17 | 702.73 |
PAT Growth(%) | 0 | -158.74 | 305.95 | 9.92 | -12.08 | 222.34 | -236.09 | -326.78 | 56.44 | 205.79 |
EPS Growth(%) | 0 | -158.74 | 305.95 | 9.92 | -12.07 | 222.34 | -236.09 | -326.78 | 56.44 | 205.79 |
Debt/Equity(x) | -1.87 | -1.59 | -2.01 | -2.24 | -2.53 | -2.72 | -3.42 | -1.51 | -1.13 | -1.33 |
Current Ratio(x) | 0.6 | 0.6 | 0.7 | 0.73 | 0.71 | 0.77 | 0.7 | 0.69 | 0.72 | 0.75 |
Quick Ratio(x) | 0.57 | 0.56 | 0.66 | 0.68 | 0.63 | 0.72 | 0.65 | 0.65 | 0.68 | 0.72 |
Interest Cover(x) | 1.27 | 0.92 | 1.14 | 1.17 | 1.13 | 1.33 | 0.59 | -0.63 | 0.23 | 1.73 |
Total Debt/Mcap(x) | 0.75 | 0.43 | 0.51 | 0.79 | 1.06 | 0 | 0 | 1.7 | 0 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.97 | 74.97 | 74.97 | 74.97 | 74.97 | 74.97 | 74.97 | 74.97 | 74.97 | 74.97 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 25.03 | 25.03 | 25.03 | 25.03 | 25.03 | 25.03 | 25.03 | 25.03 | 25.03 | 25.03 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About